AOD-9604 5mg New Dual-Chamber Pen — Fat Metabolism + Lipolysis Support

AOD-9604 is a research compound studied for supporting fat metabolism, fat breakdown (lipolysis), and metabolic efficiency. The dual-chamber pen provides convenient, precise dosing for research protocols.

How it works (Mechanism of Action)

AOD-9604 is a modified fragment of growth hormone developed to isolate its fat-metabolism signaling. Research suggests it promotes lipolysis (fat breakdown) while reducing lipogenesis (fat storage), primarily through β3-adrenergic–related pathways, without activating the full growth hormone receptor pathway.

Research-Associated Benefits

• Supports fat metabolism
• Promotes lipolysis (fat breakdown)
• Helps reduce fat storage pathways
• Supports metabolic efficiency
• Designed to target fat-metabolism signaling without directly stimulating IGF-1 production in published research

Research dosing (commonly referenced)

Published research has commonly investigated:

• 250–500 mcg once daily (protocol dependent)

These are research references, not consumer directions.

Disclaimer

For research & educational use only. Not intended to diagnose, treat, cure, or prevent any disease.